Saratoga Springs drug manufacturing facility
Regeneron Pharmaceuticals, Inc., Saratoga Springs, New York
Saratoga Springs drug manufacturing facility in Saratoga Springs, New York is Regeneron Pharmaceuticals, Inc.’s plant for biologic medicines (infectious disease and oncology). Status: announced as of November 13, 2025. Regeneron Pharmaceuticals, Inc. announced $2.0 billion and 1,000 jobs. Primary source: governor.ny.gov, checked November 12, 2026.
- Status
- Announced
- Announced investment
- $2.0 billion
- Announced jobs
- 1,000
- Industry
- Pharmaceuticals
- Sheet
- NY-26
- Revised
- November 12, 2026
Status timeline
- Announcedgovernor.ny.gov
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Regeneron Pharmaceuticals, Inc. |
|---|---|
| Plant | Saratoga Springs drug manufacturing facility |
| Location | Saratoga Springs, New York |
| Industry | Pharmaceuticals |
| Product | Biologic medicines (infectious disease and oncology) |
| Announced investment | $2.0 billionMore than $2 billion; conversion of a former printed-material plant on Duplainville Road |
| Announced jobs | 1,000 |
| Last checked | November 12, 2026 |
Sources
- Governor Hochul: Regeneron to invest more than $2 billion in Saratoga County facility (state release, governor.ny.gov, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.